Business Insider
My Markets Watchlist
Markets Stocks

Fresenius Medical Care (FMC) St. Stock , FMCQF

50.09 EUR -0.13 -0.26%
12:24:20 PM STU
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar


Fresenius Medical Care (FMC) St. Stock Snapshot

16.87 B
Market Cap in USD
293.41 M
Number of Shares
293.41 M
Total Number of Shares
1.44
Dividend in EUR
3.26
Dividend Yield
24.09
P/E Ratio
71.45
Free Float in %
1.83
EPS in EUR
49.68
Book Value per Share in EUR
8.13
Cash Flow per Share in EUR

Historical Prices for Fresenius Medical Care

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Fresenius Medical Care Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price

Fresenius Medical Care Estimates* in EUR

  2025 2026 2027 2028 2029
Revenue 19,626 20,289 21,054 21,941 23,039
Dividend 1.52 1.69 1.86 1.68 2.01
Dividend Yield (in %) 3.03 % 3.36 % 3.70 % 3.34 % 4.01 %
EPS 3.69 4.19 4.61 5.20 5.85
P/E Ratio 13.59 11.99 10.88 9.65 8.58
EBIT 2,108 2,301 2,491 2,790 3,054
EBITDA 3,729 3,865 4,055 4,158 3,961
Net Profit 1,007 1,208 1,328 1,518 1,505
Net Profit Adjusted 1,114 1,245 1,379 1,568 -
Pre-Tax Profit 1,720 1,988 2,177 2,477 2,514
Pre-Tax Profit Reported 1,644 1,982 2,171 2,433 -
EPS (Non-GAAP) ex. SOE - - - - -
EPS (GAAP) 3.21 3.97 4.36 5.54 5.15
Gross Income 5,252 5,671 5,968 6,402 6,540
Cash Flow from Investing -712 -799 -829 -906 -857
Cash Flow from Operations 2,676 2,946 3,107 3,115 2,883
Cash Flow from Financing -1,020 -1,415 -1,082 -881 -110
Cash Flow per Share 8.40 9.03 9.59 11.33 8.89
Free Cash Flow 1,611 1,802 1,911 1,576 1,641
Free Cash Flow per Share 6.20 6.57 7.00 6.62 6.91
Book Value per Share 51.37 54.25 57.10 61.53 63.38
Net Debt 9,169 8,206 7,272 6,157 5,430
Research & Development Exp. 192 198 208 208 213
Capital Expenditure 888 934 969 937 974
Selling, General & Admin. Exp. 2,886 2,969 3,413 3,442 3,943
Shareholder’s Equity 15,535 16,323 17,247 18,752 19,831
Total Assets 33,957 34,290 34,969 36,539 38,450
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts 8 5 5 18 18
Average Estimate 0.718 EUR 0.855 EUR 0.990 EUR 3.695 EUR 4.185 EUR
Year Ago 0.242 EUR 0.637 EUR 0.726 EUR 1.833 EUR -
Publish Date - - - - -
Revenue Estimates
No. of Analysts 9 5 5 17 17
Average Estimate 4,772 EUR 4,998 EUR 5,018 EUR 19,626 EUR 20,289 EUR
Year Ago 4,725 EUR 4,766 EUR 4,760 EUR 19,338 EUR -
Publish Date - - - - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. EUR

2024 2023 2022 2021 2020 2019 2018
Sales 19,337.75 19,454.12 19,395.32 17,618.41 17,863.68 17,475.22 16,547.30
Change of sales in % -0.60 0.30 10.09 -1.37 2.22 5.61 -6.95
Gross profit on sales 4,763.63 4,933.42 5,309.64 5,076.68 5,544.72 5,392.01 5,157.01
Gross profit on sales change in % -3.44 -7.09 4.59 -8.44 2.83 4.56 -14.08
Operating income 1,644.04 1,587.26 1,753.60 1,998.38 2,209.94 2,139.24 2,337.10
Operating income change in % 3.58 -9.49 -12.25 -9.57 3.30 -8.47 7.76
Income before tax 922.05 911.23 1,152.72 1,479.69 1,841.87 1,766.44 2,663.39
Income before tax change in % 1.19 -20.95 -22.10 -19.66 4.27 -33.68 37.19
Income after tax 537.91 499.00 673.41 969.31 1,164.38 1,199.62 1,981.92
Income after tax change in % 7.80 -25.90 -30.53 -16.75 -2.94 -39.47 54.86

Balance Sheet in Mio. EUR

2024 2023 2022 2021 2020 2019 2018
Total liabilities 17,798.07 19,103.27 20,304.94 20,387.52 19,357.73 19,707.50 13,340.31
Long-term liabilities per share 41.37 44.28 47.16 44.81 45.06 42.57 23.05
Equity 15,768.51 14,826.54 15,449.18 13,979.04 12,331.31 13,227.24 12,901.96
Equity change in % 7.02 -2.64 10.16 13.23 -6.21 1.70 19.74
Balance sheet total 33,566.58 33,929.81 35,754.11 34,366.56 31,689.04 32,934.74 26,242.27
Balance sheet total change in % -1.07 -5.10 4.04 8.45 -3.78 25.50 9.23

Key Data in EUR

2024 2023 2022 2021 2020 2019 2018
Sales per share 65.91 66.30 66.14 60.12 60.70 57.72 53.86
P/E ratio (year end quote, basic EPS) 24.09 22.32 13.31 17.27 17.22 16.64 8.76
P/E ratio (year end quote, diluted EPS) 24.09 22.32 13.31 17.28 17.24 16.65 8.78
Dividend yield in % 3.26 3.13 3.66 2.36 1.96 1.82 2.07
Equity ratio in % 46.98 43.70 43.21 40.68 38.91 40.16 49.16
Debt ratio in % 53.02 56.30 56.79 59.32 61.09 59.84 50.84

Fresenius Medical Care (FMC) St. Dividend Calendar

Date Name Dividend *yield Currency
2024 Fresenius Medical Care (FMC) St. 1.44 3.26 EUR
2023 Fresenius Medical Care (FMC) St. 1.19 3.13 EUR
2022 Fresenius Medical Care (FMC) St. 1.12 3.66 EUR
2021 Fresenius Medical Care (FMC) St. 1.35 2.36 EUR
2020 Fresenius Medical Care (FMC) St. 1.34 1.96 EUR
2019 Fresenius Medical Care (FMC) St. 1.20 1.82 EUR
2018 Fresenius Medical Care (FMC) St. 1.17 2.07 EUR
2017 Fresenius Medical Care (FMC) St. 1.06 1.21 EUR
2016 Fresenius Medical Care (FMC) St. 0.96 1.19 EUR
2015 Fresenius Medical Care (FMC) St. 0.80 1.03 EUR
2014 Fresenius Medical Care (FMC) St. 0.78 1.26 EUR
2013 Fresenius Medical Care (FMC) St. 0.77 1.49 EUR
2012 Fresenius Medical Care (FMC) St. 0.75 1.43 EUR
2011 Fresenius Medical Care (FMC) St. 0.69 1.31 EUR
2010 Fresenius Medical Care (FMC) St. 0.65 1.50 EUR
2009 Fresenius Medical Care (FMC) St. 0.61 1.65 EUR
2008 Fresenius Medical Care (FMC) St. 0.73 1.87 EUR
2007 Fresenius Medical Care (FMC) St. 0.79 2.31 EUR
2006 Fresenius Medical Care (FMC) St. 0.60 1.91 EUR
2005 Fresenius Medical Care (FMC) St. 0.48 1.36 EUR
2004 Fresenius Medical Care (FMC) St. 0.45 1.76 EUR
2003 Fresenius Medical Care (FMC) St. 0.38 1.82 EUR
2002 Fresenius Medical Care (FMC) St. 0.34 2.41 EUR
2001 Fresenius Medical Care (FMC) St. 0.32 1.29 EUR
2000 Fresenius Medical Care (FMC) St. 0.29 0.93 EUR
1999 Fresenius Medical Care (FMC) St. 0.25 0.82 EUR
*Yield of the Respective Date

Fresenius Medical Care (FMC) St. Calendar

Event Estimate Info Date

Fresenius Medical Care (FMC) St. Past Events

Event Actual EPS Info Date

Fresenius Medical Care Profile

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
4
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Fresenius Medical Care Management

Name Job
Michael Sen Chairman-Supervisory Board
Helen Giza Chief Executive Officer
Craig Cordola Chief Executive Officer-Care Delivery
John C. Ma Chief Executive Officer-Care Enablement
Katarzyna Mazur-Hofsaess Chief Executive Officer-Care Enablement
Martin Fischer Chief Financial Officer
Stefanie Lang Deputy Chairman-Supervisory Board
Dominik Heger Executive VP & Head-Investor Relations
Franklin W. Maddux Global Chief Medical Officer
Jörg Häring Global Head-Legal, Compliance & Human Resources
Marcus Kuhnert Independent Member-Supervisory Board
Pascale Witz Independent Member-Supervisory Board
Shervin Joe Korangy Independent Member-Supervisory Board
A. Gregory Sorensen Independent Member-Supervisory Board
Ralf Erkens Member-Supervisory Board
Manuela Stauss-Grabo Member-Supervisory Board
Frank Michael Prescher Member-Supervisory Board
Beate Haßdenteufel Member-Supervisory Board
Regina Karsch Member-Supervisory Board
Sara Hennicken Member-Supervisory Board